InvestorsHub Logo

jimsgtx

03/10/15 12:13 PM

#210078 RE: vanessapu #210077

Betabodies... And we'll have plenty of cash to keep doing research! Yeah, that's the ticket.

The Other Guy

03/10/15 12:15 PM

#210080 RE: vanessapu #210077

I hope the drug eventually gets to be generic! That would mean, bavi was approved about 20 years before being generic. It would also mean the stock would have soared well before that. Bavi going generic is the least of anyone's concerns.

In addition, Avid is an asset to this company. On the slightest chance bavi does not get approval, Avid will actually keep some valuation to PPHM.

jimsgtx

03/10/15 12:17 PM

#210082 RE: vanessapu #210077

And don't forget... If bavi becomes a blockbuster... We'll be in the game with the big boys... We can start scooping up the smaller guys who's drugs have already been thru promising phase trials.

Couch

03/10/15 12:23 PM

#210086 RE: vanessapu #210077

My assumption is Bavi would be approved by then - and what if it isn't- how does selling Avid at this point help the company should Bavi not be approved? Avid adds value to the company now and selling it - explain to me in detail how that would benefit the company? Makes no sense to me.